GENE ONLINE|News &
Opinion
Blog

NVX-CoV2373
Asia-Pacific COVID-19 Vaccine
SK Bioscience Files for Approval of Novavax’s COVID-19 Vaccine
2021-11-17
COVID-19 mRNA Vaccine
South Korea Seeks Global Partners for Upping COVID-19 Vaccine Production
2021-06-18
COVID-19 Vaccine
Novavax to Seek Regulatory Approval After COVID-19 Vaccine Displays 90% Efficacy in US Trial
2021-06-15
COVID-19 Vaccine
SK Bioscience Receives EU-GMP Certification for COVID-19 Vaccine Production Plant, Making it Korea’s First
2021-05-18
COVID-19 COVID-19 Variant
Novavax’s Protein Subunit Vaccine Shows 89.3% Efficacy in Phase 3 UK Trial
2021-01-29
Asia Highlights｜July
2020-07-31
COVID-19
Novavax to Deliver 100 Million COVID-19 Vaccine Doses by January 2021
2020-07-12
COVID-19
COVID-19 Vaccine: Novavax Gets Funding from the US Department of Defense
2020-06-09
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top